Background and Problem Statement As a consequence of recent progress in interoperability and healthcare data exchange, the data quality problem is no longer isolated to local organizations and businesses; it is systemic and more evident than ever. It negatively affects patient care, patient safety, public health, clinical research, insurance claims processing, and the administrative cost … Read more
With months to go, the 2024 election cycle has already been filled with many twists and turns, creating uncertainty about the outcome and its impact on governance. Join three Leavitt Partners experts with significant DC policy experience as they sift through the noise to analyze the current state of play and what it means for … Read more
This webinar was held on August 14, 2024. While legal experts assess the recent U.S. Supreme Court rulings, federal and state agency leaders face significant questions about how their agencies and their responsibilities will be impacted. This webinar featured insightful discussions with former federal and state agency leaders exploring the known and yet-to-be determined impacts … Read more
25 Tribal Organizations, Medical Schools and Others to Advocate for Policies that Empower New Physicians to Practice in Tribal Communities. Today, 25 urban and rural Tribal organizations, medical schools, health plans, teaching hospitals, medical residencies, and physician advocates launched the American Indian Medical Education Strategies (AIMES) Alliance. The AIMES Alliance, whose mission is to address … Read more
Leavitt Partners, an HMA Company, is pleased to announce that Mark Marciante has joined the company’s digital health team of experts. He will be a director located in the company’s Washington, D.C., office. Marciante has extensive experience in digital health, successfully driving transformative initiatives for healthcare payers over the past decade. As director of engineering … Read more
The 2024 election cycle will dominate the headlines, but there will be meaningful health policy both in Congress and in the Biden Administration. This year the Leavitt Partners Political Checkpoint is a video featuring Governor Michael Leavitt and members of our D.C. team talking about short term and longer term outlook on major issues and the … Read more
The Save Rare Treatments Task Force, a new multi-sector public policy and advocacy collaboration convened by Leavitt Partners, an HMA Company, publicly launched this week and today released a letter of support for recently introduced, bipartisan, bicameral legislation. The Task Force is comprised of organizations representing persons living with rare diseases, biopharmaceutical innovators, and other … Read more
Watch Leavitt Partners Principal Elizabeth Wroe, as she explains the potential impact of a government shutdown on health care priorities. Download the presentation slides here.
Rebecca Nielsen, Managing Director, Leavitt Partners, an HMA CompanySpencer Morrison, Associate Principal, Leavitt Partners, an HMA Company PillPack boasts the tagline, “Pharmacy Simplified.” The mail-order pharmacy successfully streamlined the activities associated with managing medications. It illuminated for its customers what medications they needed to take next, and at what time, by packaging meds in a … Read more
Amy Comstock Rick, former president and chief executive officer (CEO) of the Food and Drug Law Institute (FDLI), joined Leavitt Partners, an HMA Company as a principal on March 20. Rick has over 30 years of experience leading organizations, executing strategy, transforming organizational culture, building consensus, and advocating policies across constituencies. “Amy is widely respected … Read more
